Cardiac Assist Devices Market - Forecast (2022 - 2027)

 Cardiac assist devices market size was valued at $1,307 million in 2020 and is anticipated to grow at a CAGR of 8.2% during the forecast period 2021-2026. The cardiac assist devices industry growth rate is attributed to the increasing focus on the growing demand for efficient cardiac assist devices in developed countries, along with an increase in the prevalence of heart failure which is poised in bringing new opportunities. Cardiac Assist Devices (CADs) are blood pumps that support the circulatory functions of severely ill cardiac patients. CADs are usually implanted in patients with acute heart failure, for example after myocardial infarction or after surgery. Furthermore, patients awaiting a heart transplant, whose cardiac function deteriorates before a suitable organ can be implanted, need circulatory support for the period before a transplant. In selected patients with dilative cardiomyopathy, a CAD might be removed after a prolonged support period, and when the patient’s own heart has recovered and can maintain blood circulation. Moreover, adoptions of cardiac assist devices over the study period coupled with the emergence of state-of-the-art healthcare technologies have fueled the uptake of minimally invasive surgery for faster and better outcomes. However, the comparatively high prices of the ventricular assist devices (VADs) for advanced heart failure coupled with expensive follow-up care are poised to hinder the Cardiac Assist Devices market.

Report Coverage

The report: “Cardiac Assist Devices Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cardiac Assist Devices Market:
By Product Type: Ventricular Assist Device, Total Artificial Heart, Intra-Aortic Balloon Pump and Others.

By Modality: Transcutaneous, Implantable.

By Application: Bridge-to-transplant (BTT) Therapy, Destination Therapy, Bridge-to-recovery (BTR) Therapy, Bridge-to-candidacy (BTC) Therapy and Others.

By Distribution Channel: Hospital, Ambulatory Surgical Centers and Others.

By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC (China, Japan, India, South Korea, Australia and Others), South America(Brazil, Argentina and Others) and RoW (Middle East and Africa).


Key Takeaways

  • The factors such as rising adoption of innovative various cardiac assist devices owing to rise in the incidence of heart failures and several patients with cardiovascular diseases (CVDs) such as myocardial infarction are amongst the major factor projected to impel growth of cardiac assist devices market.

  • Additionally, factors such as rising government funding for product development and ongoing research activities are to create opportunities paving a way for the growth in the market during the forecast period 2021-2026.

  • Cardiac Assist Devices Market Segment Analysis - By Modality

  • In 2020, on the basis of modality, implantable segment accounted for the largest segmental revenue of the Cardiac Assist Devices market. The implantable held the largest market on account of the fact that this modality type ventricular assist devices has shown a surge in the usage owing to an increase in the number of several myocardial infarction cases globally. Also, the segment is to hold its dominance through the forecast period 2021-2026 with a healthy growth in CAGR of 8.69% as this segment is visualizing the entry of numerous market players specifically focused into the innovation of new products hence; broadening the scope of application is also poised to hold the market share.


Cardiac Assist Devices Market Segment Analysis - By End Users

On the basis of end users, hospital segment accounted for the largest segmental revenue of the cardiac assist value market in 2020. The large share can be attributed to the high adoption of cardiac assist devices among hospitals, owing to the emergence of the COVID-19 pandemic coupled with the increase in the number of several cardiovascular diseases cases such as myocardial infarction globally are also to boost the adoption of such devices in hospitals, and this will accelerate the growth of the hospital segment in the CADs market during the forecast period 2021-2026. 

On the other hand, ambulatory care centers segment is projected to dominate over the forecast period 2021-2026 with a CAGR of 8.50%. The ambulatory care centers are to witness a healthy growth owing to the fact that the pandemic has had quite a significant effect on the CAD’s sales market; owing to the rising percentage of total transcutaneous surgical procedures occurring in free-standing ASCs which has had a significant impact on inpatient management, necessitating a dedicated workforce, patient isolation, and strict visiting hour policies which is to promote the growth. Apart from this, outpatient visits have been restricted to minimize interaction between patients and hospital staff, with significant implications for pre-operative care quality and the human side of medicine which is also anticipated to offer significant growth for the ambulatory care centers segments during the forecast period 2021-2026. 


Cardiac Assist Devices Market Segment Analysis - By Geography

North America is the major region dominating the cardiac assist devices market with a market share of 37.90% in the year 2020. This can be attributed to the fact that the rise in demand for cardiac assist devices sales is increasing owing to the availability of advanced features such as connectivity with Bluetooth and smart countdown. Furthermore, the presence of well-established reimbursement policies and increasing awareness pertaining to ventricular assist devices such as bridge-to-transplant, destination therapies, etc. are boosting the cardiac assist devices market share, which further fuels the regional market.

However, Asia-Pacific is projected to be the significant-growing market during the forecast period 2021-2026 as several countries such as India and China has rising expenses on healthcare followed by a vast set of untapped opportunities in the regional markets such as the “Make in India” campaign and increasing public and private investments which is poised to propel the market growth throughout the cardiac assist devices market forecast period 2021-2026. Moreover, in Asia-Pacific countries there is rising geriatric population in countries that are poised to result in a surge in several myocardial infarction cases thereby, augmenting the regional market growth.


Cardiac Assist Devices Market Drivers

Rapid Adoption Of Cardiac Assist Devices 

The cardiac assist devices market is poised to receive upswing demand owing to the rapid increase in demand for several cardiac assist devices and attributed to the fact that these kits are equipped with several cutting-edge innovations, such as a smart countdown and Bluetooth connectivity that has resulted in all major pharmaceutical companies focusing on such innovative formulation technologies. Moreover, there is also a rise in the number of incidence of patients with heart failures such as myocardial infarction over the globe thereby, leaving them with little time to seek medical help hence, there is a rising use of cardiac assist devices and is to propel the market growth over the forecast period 2021-2026.


Cardiac Assist Devices Market Challenges

High Price Of Cardiac Assist Devices

One of the major factors lowering the cardiac assist devices is owing to the fact that advanced cardiac assist devices are sold at higher prices coupled with expensive follow-up care which is hindering the market growth during the forecast period 2021-2026. Moreover, these cardiac assist devices also pose certain risks for implantation procedures such as infection, blood clotting, problems with device, etc. which is also acting as a challenge across the globe. 


Cardiac Assist Devices Market Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Cardiac Assist Devices market. In 2020, Cardiac Assist Devices market share is fragmented by the top ten players present in the market. The Cardiac Assist Devices market top 10 companies are Calon Cardio-Technology Ltd., MAQUET GmbH & Co., Biophan Technologies, Berlin Heart GmbH, Teleflex Incorporated, Heart Ware International, Bioheart, Abiomed Inc., Thoratec Corporation, SynCardia Systems and others.


Buy Now


Acquisitions/Product Launches

  • In October 2019, Abbott received FDA approval for the HeartMate 3 left ventricular assist device (LVAD) as destination therapy for advanced heart failure patients who are ineligible for a transplant.
  • In May 2019, Abiomed launched the Impella CP commercially with SmartAssist at the 2019 Society for Cardiovascular Angiography & Interventions (SCAI).


"For more Lifesciences and Healthcare related reports, please click here"


Location: United States

Comments

Post a Comment

Popular posts from this blog

Inflammatory Bowel Disease Market Forecast (2022-2027)

Image
  Inflammatory Bowel Disease Market Size is estimated to reach   $26.3 billion   by 2027 and is poised to grow at a   CAGR of 5.9%   over the forecast period of 2022-2027. Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. It includes ulcerative colitis, a condition in which inflammation and soreness of the superficial lining of the rectum and colon, and in Crohns disease affect any part of the gastrointestinal tract. The cause of IBD is unknown, but it mostly occurred after weaken immunity power. Some agent or combination of agents such as bacteria, viruses, and antigens are considered as responsible to trigger the immune system, and causing inflammation. The common symptoms of IBD are abdominal pain, weight loss, persistent diarrhea, rectal bleeding, and fatigue. To treat such disease medication with amino-salicylates, immunomodulators,   antibiotics , corticosteroids, ...
Read more

Narcolepsy Market - Forecast(2022 - 2027)

  Narcolepsy Market size is estimated to be $2.68 billion in 2019, growing at a CAGR of 10.4% during the forecast period 2020-2025.Increasing obese population and rising prevalence of narcolepsy is a major factor driving the narcolepsy market during the forecast period 2020-2025.Futhermore, narcolepsy is a lifelong nervous system disorder that effect a person quality of life. Moreover, according to the Narcolepsy Network narcolepsy affected an estimated 1 in every 2000 people in the U.S. That’s 2000,000 Americans and approximately 3 million worldwide. Furthermore, people suffering from narcolepsy frequently enter into cataplexy and REM sleep within every 15 minutes of falling asleep, thereby driving the demand of proper narcolepsy treatment which in turn is boosting the narcolepsy market. In addition sleep apnea symptoms are similar to narcolepsy and patients go through excessive daytime sleepiness (EDS) thereby raising the demand of narcolepsy treatment. Request Sample Report Cov...
Read more

Plant Growth Regulators Market - Forecast(2022 - 2027)

Global Plant growth regulator market is valued $1,550 million in the year 2017 and is expected to grow at a CAGR of 4.6% from 2018 to 2023. The market is growing steadily due to wide adoption of ethylene across groups. Cytokinins is having the highest market share in the year 2017 and is followed by Ethylene which is valued $448.5 million and $386.2 million respectively in the year 2017 and is anticipated to grow with a CAGR of 4.6% and 5.9% from the year 2018 to 2023. Request Sample What is plant growth regulator?Plant growth regulators are the synthetic or natural chemicals that are responsible in controlling the growth and development of the plant. Natural plant growth regulators are produced with in specific parts of plants in minimal qualities and migrate to other parts, manipulating several physiological functions to regulate the plant’s growth such as promoting plant cell division and cell expansion, leaf expansion, retarding senescence of the leaves, ripening of fruits & v...
Read more